AARTIDRUGS

What Aarti Drugs promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q1 FY27

what the last two calls moved 22 tracked 3 delivered 7 missed 12 open
  • Project Commissioning delivered, diluted said Q2 FY25 Promised: Commence operations in Q3 FY25 Q1 FY27: The plant is confirmed to be operating at nearly 65% utilization, confirming the promise remains fulfilled, albeit with the initial delay.
  • Long-term Revenue went quiet said Q2 FY25 Promised: INR 4,200 crores to INR 4,500 crores Q1 FY27: The long-term consolidated revenue target for FY27 was not mentioned for the fifth consecutive quarter.
  • Volume Growth revised up said Q2 FY26 Promised: 15% to 20% Q1 FY27: Management firmed up guidance, stating 'for next two years, we are very well poised for that 10% to 15% kind of a volume growth', revising guidance back up from the 'strive for 8-10%' comment.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 22 tracked commitments for Aarti Drugs — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens